GE HealthCare Stocks Dive 14% Amid China's Rare Earth Export Ban Shockwave
GE HealthCare's stock fell 14% after China announced export controls on rare earth materials, critical for medical technology, amid escalating US-China trade tensions.
GE HealthCare News
GE HealthCare Shares Dive 14% Amid China's Rare Earth Export Ban Shockwave
GE HealthCare's shares fell 14% after China announced export controls on rare earth materials, crucial for medical imaging equipment, amid US-China trade tensions.
GE HealthCare Shares Dive 14% as China's Rare Earth Export Ban Sparks Supply Fears
GE HealthCare's stock fell 14% after China imposed export controls on rare earth materials, crucial for medical equipment. The move, seen as retaliation against US tariffs, has spa...
GE HealthCare Stock Plummets 14% Amid China's Rare Earth Export Ban Shockwave
GE HealthCare Technologies, Inc. sees a 14% stock drop after China announces rare earth export controls, sparking supply chain fears in healthcare technology.
GE HealthCare Shares Dive 14% Amid China's Rare Earth Export Ban Shockwave
GE HealthCare Technologies, Inc. shares plummeted 14% after China imposed export controls on rare earth materials, crucial for medical equipment. The move, part of retaliatory meas...
GE HealthCare Shares Dive 14% Amid China's Rare Earth Export Ban Shockwave
GE HealthCare's stock fell 14% after China announced export controls on rare earth materials, crucial for medical imaging. This move, seen as retaliation against US tariffs, has sp...
GE HealthCare's Stock Dives 14% Amid China's Rare Earth Export Ban Crisis
GE HealthCare Technologies' stock plummeted 14% after China announced export controls on rare earth materials, crucial for medical equipment, amid escalating US-China trade tension...
GE HealthCare's Stock Plummets 14% Following China's Shocking Rare Earth Export Ban
GE HealthCare's stock price fell by 14.02% to $61.9050 following China's ban on rare earth exports, signaling potential disruptions in global supply chains and the healthcare techn...
GE HealthCare Reports a 2.1% Revenue Increase to $5.3 Billion in Q4, Signaling Strong Growth
GE HealthCare Technologies Inc. reports a 2.1% revenue increase in Q4 2024, reaching $5.3 billion, with net income and EPS significantly rising. The company forecasts a promising a...
GE HealthCare Achieves a 2.1% Revenue Growth in Q4 2024, Reaching $5.3 Billion
GE HealthCare reports a 2.1% revenue increase in Q4 2024, reaching $5.3 billion, with net income and EPS soaring by 78%. The company anticipates continued growth with a positive ou...
GE HealthCare Reports a 2.1% Revenue Increase in Q4 2024, Reaching $5.3 Billion
GE HealthCare Technologies Inc. reported a 2.1% increase in Q4 2024 revenue to $5.3 billion, with net income and EPS both up by 78%. The company also provided a positive outlook fo...
